A US-based academic nephrologist with subspecialty expertise in glomerular and complement-mediated kidney disease shares perspectives on IgA nephropathy (IgAN) patient classification, epidemiology, the patient journey, treatment options, use of supportive care and targeted therapies, and areas of unmet need. In addition, the KOL shares views on some promising emerging therapies.

This interview was conducted on March 17, 2026.

If you are a Datamonitor Healthcare client, you may access the interview from our KOL Insight channel.

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal.

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900. 

For our disclosures, please read the Biomedtracker Research Standards.